Frenova bolsters research site lineup
Frenova Renal Research is expanding its site network to accelerate clinical trial enrollment with the addition of more than 450 PIs.
Frenova Renal Research is expanding its site network to accelerate clinical trial enrollment with the addition of more than 450 PIs.
WuXi AppTec acquires Pharmapace to bolster its biometrics and clinical development service offerings worldwide.
Janssen and Iktos Pharmaceuticals enter an agreement to bolster small molecule discovery using virtual drug design technology.
Amgen is collaborating with Syapse to support clinical trial enrollment and accelerated drug development using real-world evidence-based insights.
Merck continues its multi-year restructuring process with a program that could cost up to $1.2bn and has a provisional end date of 2023.
Acacia Pharma receives a second CRL from the US FDA regarding its NDA, after GMP deficiencies during API production were revealed again.